$$$$$$$~BIG OTC DD PICKS AND LOW FLOAT MOVERS$$$$$$$

[remind2]

GOVX @ .08: Top Zika vaccine play.


GeoVax is a partner with the National Institute of Health & The Centers for Disease Control.

GOVXs tiny 42m share float is 9.5% owned by Emory University. The biggest private vaccine lab in the world.

Much of the rest of the float is held by insiders.

GOVX is in Phase 2 trials with the Feds on an HIV vaccine that is proven in Phase 1 to work in primates.

The Feds gave GOVX $7.8M dollars in June, 2016 for their HIV vax research.

GOVX is due to get Fed Zika funding at any time that is GREATER than the current market cap of the entire company. GOVX, as a CDC & NIH partner will , without doubt, receive millions of research $$.

GOVX is one of the great companies to own right now.

Investors should buy some GOVX now.

LINK: $7.8M Fed $$s for HIV vax
http://www.geovax.com/news-events/entry/2016/08/02/geovax-awarded-nih-contract-for-up-to-7-8-million-to-manufacture-hiv-vaccine-for-advanced-human-clinical-trials.html

GeoVax Zika Funding news:


GOVX Fed Zika Funding news:
http://www.pharmpro.com/news/2016/04/geovax-seeks-funding-speed-zika-vaccine-program

NOTE: GOVX VP for Vaccine Research was the former Chief Scientist for Sanofi, the biggest vaccine maker in the world.

Buy GOVX. It is a serious money maker.